KCs Certification for Robotics in Korea: Hyundai’s Atlas Shift

South Korea is strengthening oversight of advanced robotics as industrial humanoids move closer to commercialization. The evolving KCs certification for robotic products is gaining importance alongside Hyundai Motor Group’s latest announcement distinguishing its research prototype from a mass-production factory model.

While the Atlas prototype showcased at CES 2026 demonstrated high agility and tumbling capabilities, Hyundai confirmed that a simplified version will be deployed in factories from 2028. This production model prioritizes cost efficiency, durability, and ease of maintenance over advanced motion performance. Robotic products and components usually require KCs certification in order to be approved for import and sale in Korea.

Certification Challenges for Evolving Robot Designs

The differences between prototype and production models introduce new considerations under the KCs certification framework. Korea’s system traditionally evaluates electrical safety, electromagnetic compatibility, and reliability, but humanoid robots add complexity due to integrated AI, advanced actuators, and multi-axis mobility.

For instance, the prototype’s parallel actuator structure supports balance and shock absorption, while the production version adopts a simpler joint design similar to industrial robotic arms. Although less flexible, this approach enhances environmental resistance and reduces manufacturing costs—factors that may support compliance but still require thorough safety validation.

Key features such as 360-degree vision, high payload capacity, and wide operating temperature ranges will likely require system-level testing to ensure safe real-world performance in industrial settings.

Implications for Market Entry and Compliance

For manufacturers, the shift toward scalable humanoid robots underscores the need to integrate compliance early in product development. Simplified designs must still meet KCs requirements, particularly for operational safety and component integrity.

Hyundai’s strategy—balancing affordability with performance and exploring service-based deployment models—reflects broader industry trends. However, it also raises additional compliance considerations related to maintenance, lifecycle management, and software updates.

As Korea advances its regulatory approach to robotics, companies should closely track KCs certification developments and engage proactively with certification bodies to ensure efficient market access.

Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.

Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673

Email: info@korea-certification.com

For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.

Korea MFDS Regulation Shapes Emerging Oral Obesity Drug Market

The rapid expansion of oral obesity treatments is drawing increased regulatory attention, particularly under the Korea MFDS framework governing pharmaceutical approvals. As global pharmaceutical companies shift from injectable to oral formulations, the Korea MFDS regulatory pathway is expected to play a critical role in determining how quickly these innovative therapies enter the domestic market. Korean developers are actively aligning their research and commercialization strategies with evolving international and local compliance requirements. Pharmaceutical products usually require MFDS approval in order to be approved for import and sale in Korea.

The growing interest in glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and orforglipron, reflects a broader trend toward more convenient, patient-friendly drug delivery methods. Oral formulations eliminate the need for cold-chain logistics and injections, which can simplify distribution and improve patient adherence. However, these advantages also require thorough regulatory evaluation to ensure safety, efficacy, and quality standards are met before market entry.

Regulatory Pathways and Product Differentiation

Internationally, leading products such as Novo Nordisk’s Wegovy tablets and Eli Lilly’s Foundayo have already received approval in the United States, demonstrating strong clinical performance in weight reduction. As these products expand into global markets, manufacturers must navigate country-specific regulatory frameworks, including Korea’s MFDS requirements for clinical data, manufacturing standards, and labeling compliance.

In Korea, regulatory authorities have also intensified oversight in response to concerns about counterfeit or improperly marketed weight loss products. This has led to stricter enforcement actions and greater scrutiny of health claims, particularly in the dietary supplement and pharmaceutical sectors. For companies seeking MFDS certification, this environment underscores the importance of robust clinical evidence and transparent product positioning.

At the same time, Korean pharmaceutical companies are pursuing differentiated approaches to obesity treatment development. These include injectable therapies tailored to local patient populations, oral drug candidates advancing through clinical trials, and alternative delivery systems such as transdermal patches. Next-generation products, including multi-action and small-molecule GLP-1 therapies, are also under development, reflecting efforts to enhance efficacy and patient convenience while meeting regulatory expectations.

Market Access and Global Expansion Considerations

The global obesity treatment market has seen significant growth, driven by rising prevalence rates and increased demand for effective therapies. For Korean companies, expanding into international markets requires not only meeting MFDS standards but also aligning with regulatory requirements in other jurisdictions. Conversely, foreign manufacturers aiming to enter Korea must prepare for MFDS review processes, which may include additional data submissions and local clinical considerations.

As oral obesity treatments continue to gain traction, regulatory compliance will remain a key factor influencing market access and product success. The Korea MFDS is expected to maintain a central role in evaluating these therapies, balancing innovation with patient safety. Further regulatory updates and guidance may be available through official certification resources and industry publications.

Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.

Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673

Email: info@korea-certification.com

Cold-Chain Logistics Robot Debuts with Subzero Capability at Modex 2026

LG CNS introduced a cold-chain logistics automation system capable of operating at temperatures as low as minus 26 degrees Celsius, targeting expanded adoption in North America’s temperature-controlled supply chain sector. The Mobile Shuttle robot system was unveiled at Modex 2026 in Atlanta, a major industry exhibition. Engineered for subzero environments, the solution is intended for applications in food distribution and retail logistics, where consistent performance under extreme conditions is critical. Robotic products and components usually require KCs or KC EMC certification to be approved for import and sale in Korea.

The system deploys fleets ranging from dozens to hundreds of robots that navigate warehouse racks at speeds of up to 1.5 meters per second, each supporting loads of up to 1,500 kilograms. Its four-directional shuttle design allows horizontal and vertical movement, reducing routing constraints and improving operational flexibility. LG CNS reports over 30 percent higher storage efficiency compared to conventional systems, supported by high-density configurations. Integrated AI capabilities enable natural language control via chatbot interfaces, real-time diagnostics, and operational recommendations. The solution also supports diverse cargo types, including cylindrical goods such as electric vehicle batteries, while mathematical optimization tools enhance routing and throughput. The company has already deployed the system in North American facilities, including a recent installation at a bakery production site in Texas.

Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products or KGS factory registration.

Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673

Email: info@korea-certification.com

For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.

JW Pharmaceutical Gains Korean Rights to Next-Generation GLP-1 Therapy in Strategic Licensing Deal

JW Pharmaceutical has entered into a licensing agreement with China-based Gan & Lee Pharmaceuticals to obtain exclusive rights in Korea for bofanglutide, an advanced GLP-1 receptor agonist. Under the terms of the deal, JW Pharmaceutical will oversee clinical development, regulatory submissions, and commercialization within the Korean market, while Gan & Lee will supply the necessary data and documentation to support investigational new drug applications and product approvals. The total agreement value may reach $81.1 million, including an upfront payment of $5 million and additional milestone-based payments linked to approvals across multiple indications. Medical products usually require MFDS certification in order to be approved for import and sale in Korea.

The drug has demonstrated promising outcomes in clinical studies, including a Phase 2b trial where patients achieved an average weight reduction of 17.3 percent over 30 weeks with biweekly administration. JW Pharmaceutical plans to initiate Phase 3 trials in Korea later this year, targeting obesity and type 2 diabetes. The partnership aligns with growing global and regional demand for GLP-1 therapies, with the Asia-Pacific market projected to expand significantly in the coming years. Both companies emphasized that the collaboration will support the advancement of innovative treatments and broaden access to new therapeutic options in Korea.

Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, MFDS certification for medical products or KGS factory registration.

Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673

Email: info@korea-certification.com

For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.

Korea KC Safety Certification Implications for Heavy Machinery Amid Domestic Minerals Project Expansion

Korea’s KC Safety certification framework for heavy machinery and components is drawing increased attention as Korea Zinc advances a major domestic strategic minerals initiative. The company’s planned investment of 11 trillion won in a new smelter project highlights broader regulatory considerations for manufacturers operating within Korea, particularly those supplying equipment to large-scale industrial developments.

Korea Zinc has launched its “Crucible Zinc” project in the Ulsan industrial hub, where it intends to build a large smelting facility by 2029. The plant is expected to produce a diverse range of non-ferrous metals, including critical minerals used in advanced manufacturing, as well as semiconductor-grade materials. Given the project’s scale and technical complexity, compliance requirements for heavy machinery and industrial components are becoming more demanding. In Korea, such equipment generally requires KC Safety certification before it can be deployed or distributed.

KC Safety Certification Framework for Industrial Equipment

KC Safety certification is a mandatory conformity assessment system in Korea that applies to a wide spectrum of industrial and electrical products, including heavy machinery and related components. Its purpose is to ensure that products meet national standards for safety, electromagnetic compatibility, and performance prior to market entry or operational use.

For suppliers involved in large industrial projects—such as smelting, mining, or recycling operations—KC certification may be required for equipment including lifting systems, processing machinery, and electrical control units. The certification process typically involves product testing, factory inspections, and documentation review conducted by authorized Korean institutions. As industrial systems become more advanced, certification requirements may also extend to integrated technologies and complex processing systems.

Market Access and Compliance Considerations

The expansion of advanced smelting infrastructure within South Korea reflects a broader push to secure critical mineral supply chains and enhance industrial resilience. For companies supplying machinery and components domestically, this reinforces the need to address KC Safety requirements early in product design and project planning.

Manufacturers must ensure compliance with Korean standards, especially when providing equipment for high-risk environments such as metal processing or chemical handling. Without proper certification, companies may face project delays, regulatory penalties, or additional costs.

Additionally, the growing focus on recycling and recovery of rare metals—such as Germanium, Gallium, and Indium—introduces further technical considerations that can affect certification scope. Equipment used in these processes must meet strict safety and reliability expectations under Korean regulations.

As domestic industrial projects continue to scale and supply chains become more interconnected, regulatory compliance remains a key factor in ensuring smooth market access and operational readiness.

Feel free to contact us any time if you need assistance or have any
questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products or KGS factory registration.

Tel. Europe: +49-69-271
37 69 259
Tel. US: +1 773 654-2673

Email: info@korea-certification.com

For
more information you can download our free brochure “Korea
Certification Made Easy – The Booklet